How fast can you count to this #?
Deprecated: Function split() is deprecated in /home/lexchess/public_html/scienceheroes.com/modules/mod_dn/helper.php on line 218
We Need Your Help!
Do You Know This Scientist?
If you do, we welcome your input. Please share your funny stories, brief anecdotes, quotes, and photos of the scientist - as well as your own inspirational opinions. Personal accounts help bring a scientist alive and create an enduring historical picture. You can be a part of this exciting history by providing your personal account!
Please click here to learn more about how to contribute:
Participate as a Friend Scholar
Can You Write or Research?
Help us learn more about this great scientist. You can be a credited Support Scholar by contributing your knowledge about this scientist and important discovery. Entries can be as short as a single section and as easy as compiling quotes. Click here to learn more about becoming a Support Scholar:
Participate as a Support Scholar
Would you like to adopt a scientist?
Endeavor to research all the sections of a scientist. Click here to learn how to be an Expert Scholar.
Participate as an Expert Scholar
Have Historically Significant Photographs?
Participate with Photos
Click here for all the ways you can participate:
Participate to ScienceHeroes.com
Has this scientist’s science impacted your life?
Click here to tell your story or to read others’ life changing anecdotes:
Post Your Own Testimonial
(dob - )
Year of Discovery: 1987, 1990
Part of Team that Created Remarkable Hib Vaccine
Schneerson teamed with colleague John Robbins at the National Institute of Child Health and Human Development to develop the Haemophilus Influenzae type b (Hib) vaccine. Hib is the bacterium that causes Hib disease, and most commonly manifests as bacterial meningitis. Bacterial meningitis can be a devastatingly serious disease that typically strikes young children under the age of two. Since Schneerson and Robbins' successful development of the Hib vaccine, Hib disease has been virtually eradicated in the United States, with its incidence rate having fallen a remarkable 99 percent.
Haemophilus Influenzae type b (Hib) disease is an invasive disease that primarily affects children under the age of five. This is because these children lack the natural antibodies that children over the age of five and adults have to fight against Hib. Hib is thought to be an airborne disease, spread through the respiratory droplets expelled during coughing and sneezing. The most common result of Hib is bacterial meningitis, although it can also cause epiglottitis (infection and swelling of the throat), pneumonia, arthritis, and other serious conditions. Meningitis causes fever, headaches, stiffness in the neck, vomiting and, in severe cases, seizures. Both meningitis and epiglottitis may result in death. Even when death is avoided, permanent brain damage occurs in about 30 percent of meningitis cases. The majority of cases of Hib-caused meningitis occur in children under two years of age. In 1980, prior to the introduction of the Hib vaccine, there were 20,000 cases of Hib reported in the United States. Today, Hib has been virtually eradicated from the U.S., with only 341 cases being reported between 1996 and 2000. Unfortunately, due to the lack of widespread vaccination, Hib continues to be a scourge in other areas of the world. It is estimated that Hib kills 400,000 children worldwide annually.
The first vaccine Schneerson and Robbins created was a pure polysaccharide vaccine. Polysaccharides are chains of sugars, and they form the shell of the Hib bacterium. Schneerson and Robbins found that this vaccine was capable of producing an immune response in older children and adults, but not in infants less than 18 months. They next developed a so-called conjugate vaccine, in which they joined the polysaccharide capsule with a protein that allows the infant's immune system to recognize the vaccine and produce antibodies against Hib. The first vaccine, for older children and adults, was approved for use in 1987. The second, for use with younger infants, was approved in 1990. Schneerson and Robbins' ingenuity has paid tremendous dividends, saving tens of thousands of young lives and preventing lifelong disability for many more.
Introduction by Tim Anderson
Table of ContentsIntroduction
Links to More Information About the Scientist
Key Experiment or Research
Quotes by the Scientist
Quotes About the Scientist
Fun Trivia About The Science
The Science Behind the Discovery
Science Discovery Timeline
Recommended Books About the Science
Books by the Scientist
Books About the Scientist
Major Academic Papers
Links to Science and Related Information on the Subject
Links to More About the Scientist & the Science
Press release announcing Schneerson' receiving the Lasker Award:
The Lasker Foundation profile of Schneerson's research:
StopGettingSick.com article about Schneerson's research with Typhoid vaccine:
Sliders & Images here
Image Flow Here
The Science Behind the Discovery
Links to Information on the Science